FEES JESSICA 4
4 · Surface Oncology, Inc. · Filed Mar 3, 2022
Insider Transaction Report
Form 4
FEES JESSICA
See Remarks
Transactions
- Award
Common Stock
2022-03-01+38,000→ 117,329 total - Award
Stock Option (Right to Buy)
2022-03-01+108,000→ 108,000 totalExercise: $3.64Exp: 2032-03-01→ Common Stock (108,000 underlying)
Footnotes (2)
- [F1]The shares were acquired pursuant to a restricted stock unit award under the 2018 Stock Option and Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vest as follows: 40% on August 1, 2022 and the remaining 60% on August 1, 2023, so long as the reporting person remains an employee or other service provider of the Issuer on such date.
- [F2]The option vests in equal monthly installments over four years, so that all of the underlying shares shall be vested on February 8, 2026, so long as the reporting person remains an employee or other service provider of the Issuer on such dates.